Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: [Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application_2 [Phase 2]
A Phase 2 clinical trial update for Lu-177 Ludotadipep in metastatic castration-resistant prostate cancer, with the study status listed as a…
-
CLINICAL_TRIALS research · 2024-04-29Clinical Trial Update: Exploration of the Value of PSMA PET/CT in Dynamic Monitoring of the Efficacy of Novel Endocrine Therapy in Patients With Metastatic Hormone Sensitive Prostate Cancer [NA]
This clinical trial is evaluating the value of PSMA PET/CT imaging to dynamically monitor the efficacy of a novel endocrine therapy in patie…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation Therapy
The clinical trial NCT04927559 on health literacy in understanding radiation therapy information for patients undergoing definitive radiatio…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study [Phase 1]
Phase 1 pilot study evaluating PSMA-PET/MRI for radiation treatment planning in locally metastatic prostate cancer; results have been posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO) [Phase 2]
Phase 2 trial SEGNO is exploring genomic biomarker-guided neoadjuvant therapy for locally advanced or oligometastatic prostate cancer; recru…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block [NA]
This clinical trial update reports a completed study comparing the analgesic efficacy of transversus abdominis plane block and posterior app…
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: To Assess The Patient Preference for Goserelin Microsphere Versus Goserelin Implant in Patients With Prostate Cancer [Phase 2]
This Phase 2 study compares patient preference between goserelin microsphere and goserelin implant in men with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Randomized Trial of Trust in Online Videos About Prostate Cancer [NA]
This document reports the completion of a randomized trial investigating trust in online videos about prostate cancer.
-
CLINICAL_TRIALS research · 2024-04-26Clinical Trial Update: Characterization of Prostate Cancer With 3T MR
The document notes an ongoing clinical trial at Beth Israel Deaconess Medical Center using 3T MRI to characterize prostate cancer.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia
A completed clinical trial from Universität des Saarlandes investigates choline metabolites in people with prostate cancer and in individual…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Phase II, Dose Finding Study of GTx-758 [Phase 2]
Phase II dose-finding study of GTx-758 in prostate cancer was terminated; results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-17Clinical Trial Update: ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer [Phase 2]
Phase 2 trial comparing ModraDoc006/r to Docetaxel IV in metastatic castration-resistant prostate cancer has completed with results posted i…
-
CLINICAL_TRIALS trial_result · 2024-04-16Clinical Trial Update: Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones [Phase 2]
NCI-sponsored Phase 2 trial evaluating Sn-117m-DTPA bone-targeted radiation for cancer-related bone pain in men with prostate cancer that ha…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Treatment With Docetaxel Followed by Enzalutamide [Phase 2]
Phase 2 clinical trial investigating biomarker analysis in castration-resistant prostate cancer patients treated with docetaxel followed by …
-
CLINICAL_TRIALS trial_result · 2024-04-09Clinical Trial Update: A Study of Olaparib and Durvalumab in Prostate Cancer [Phase 2]
Phase 2 trial investigating olaparib plus durvalumab in prostate cancer was terminated; results posted in 2024.
-
CLINICAL_TRIALS research · 2024-04-05Clinical Trial Update: Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients [Phase 3]
Phase 3 clinical trial evaluating cytoreductive prostatectomy combined with triple or dual systemic therapy in metastatic hormone-sensitive …
-
CLINICAL_TRIALS trial_result · 2024-04-03Clinical Trial Update: High Resolution MRI Study for Prostate Cancer [NA]
Clinical trial update documenting completed high-resolution MRI study for prostate cancer, results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors [NA]
Clinical trial update for Restore study assessing sexual outcomes in gay and bisexual prostate cancer survivors; trial status completed with…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) [Phase 3]
Phase 3 EMBARK trial evaluating enzalutamide plus leuprolide in nonmetastatic prostate cancer has posted results; the study is currently not…
-
CLINICAL_TRIALS trial_result · 2024-03-25Clinical Trial Update: Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) [Phase 3]
Phase 3 trial update evaluating enzalutamide with leuprolide in nonmetastatic prostate cancer; results posted and study status is active not…
-
CLINICAL_TRIALS trial_result · 2024-03-21Clinical Trial Update: A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer [Phase 1]
Phase 1 trial results for CTT1403 in metastatic castration-resistant prostate cancer have been completed with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-20Clinical Trial Update: CivaSheet With Radical Prostatectomy & Adjuvant External Beam Radiation [NA]
Clinical trial update for CivaSheet used with radical prostatectomy and adjuvant external beam radiation in prostate cancer; study terminate…
-
FDA approval · 2024-03-19FDA Approved: BICALUTAMIDE — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for Bicalutamide submitted by Accord Healthcare Inc.
-
CLINICAL_TRIALS trial_result · 2024-03-19Clinical Trial Update: A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) [Phase 2]
A Phase 2 salvage trial (STARTAR) evaluated androgen receptor inhibition with ADT and apalutamide plus radiation therapy, followed by doceta…